TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs13082711
log Bayes Factor = 7.00766
Chromosome 3   position 27,537,909  (GRCh37) Explore rs13082711 on Ensembl!
Variant rs13082711 is listed in the   GWAS Catalog   ⇪
Variant rs13082711 is part of Cluster X0008

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I10 Essential (primary) hypertension
1.000 0.000 0.000
I10-I15 Hypertensive diseases
0.320 0.680 0.000
I13 Hypertensive heart and renal disease
0.229 0.771 0.000
I15 Secondary hypertension
0.219 0.781 0.000
I11 Hypertensive heart disease
0.216 0.784 0.000
I12 Hypertensive renal disease
0.211 0.789 0.000
I15.1 Hypertension secondary to other renal disorders
0.170 0.830 0.000
I15.0 Renovascular hypertension
0.167 0.832 0.000
I13.9 Hypertensive heart and renal disease, unspecified
0.164 0.835 0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.164 0.835 0.000
I13.1 Hypertensive heart and renal disease with renal failure
0.164 0.835 0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.164 0.835 0.000
I15.8 Other secondary hypertension
0.157 0.843 0.000
I15.2 Hypertension secondary to endocrine disorders
0.157 0.843 0.000
I11.0 Hypertensive heart disease with (congestive) heart failure
0.156 0.844 0.000
I12.0 Hypertensive renal disease with renal failure
0.146 0.854 0.000
I12.9 Hypertensive renal disease without renal failure
0.141 0.859 0.000
I11.9 Hypertensive heart disease without (congestive) heart failure
0.140 0.860 0.000
I15.9 Seconday hypertension, unspecified
0.109 0.890 0.000
H33.0 Retinal detachment with retinal break
0.000 0.896 0.104
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.083 0.917 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.083 0.917 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.081 0.919 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.081 0.919 0.000
Y49.2 Other and unspecified antidepressants
0.078 0.922 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.076 0.924 0.000
Y52 Agents primarily affecting the cardiovascular system
0.075 0.925 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.072 0.928 0.000
Y45.2 Propionic acid derivatives
0.071 0.929 0.000
Y43 Primarily systemic agents
0.068 0.932 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.068 0.932 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.066 0.934 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.066 0.934 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.065 0.935 0.000
Y49.5 Other antipsychotics and neuroleptics
0.064 0.936 0.000
Y47.1 Benzodiazepines
0.064 0.936 0.000
Y43.1 Antineoplastic antimetabolites
0.064 0.936 0.000
Y58 Bacterial vaccines
0.063 0.937 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.063 0.937 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.063 0.937 0.000
Y44 Agents primarily affecting blood constituents
0.063 0.937 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.063 0.937 0.000
Y45.1 Salicylates
0.062 0.938 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.062 0.938 0.000
Y59 Other and unspecified vaccines and biological substances
0.062 0.938 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.062 0.938 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.060 0.940 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.059 0.940 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.059 0.940 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.059 0.940 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.059 0.940 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.059 0.940 0.000
Y51.0 Anticholinesterase agents
0.059 0.940 0.000
Y45.5 4-Aminophenol derivatives
0.059 0.940 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.059 0.941 0.000
Y49.9 Psychotropic drug, unspecified
0.058 0.941 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.058 0.941 0.000
Y49.7 Psychostimulants with abuse potential
0.058 0.941 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.058 0.941 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.058 0.941 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.058 0.941 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.058 0.941 0.000
Y48 Anaesthetics and therapeutic gases
0.058 0.942 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.058 0.942 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.058 0.942 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.057 0.943 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.057 0.943 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.056 0.944 0.000
Y52.1 Calcium-channel blockers
0.056 0.944 0.000
Y45.4 Antirheumatics
0.055 0.945 0.000
Y44.6 Natural blood and blood products
0.055 0.945 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.054 0.946 0.000
Y52.7 Peripheral vasodilators
0.054 0.946 0.000
Y45.8 Other analgesics and antipyretics
0.054 0.946 0.000
Y40 Systemic antibiotics
0.054 0.946 0.000
Y43.4 Immunosuppressive agents
0.053 0.946 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.053 0.947 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.053 0.947 0.000
Y41.5 Antiviral drugs
0.052 0.948 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.052 0.948 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.052 0.948 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.052 0.948 0.000
Y47.4 Bromine compounds
0.052 0.948 0.000
Y47.3 Paraldehyde
0.052 0.948 0.000
Y47.2 Chloral derivatives
0.052 0.948 0.000
Y47.0 Barbiturates, not elsewhere classified
0.052 0.948 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.051 0.949 0.000
Y41.0 Sulphonamides
0.051 0.949 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.051 0.949 0.000
Y43.0 Antiallergic and antiemetic drugs
0.051 0.949 0.000
Y53.4 Other laxatives
0.049 0.950 0.000
Y43.9 Primarily systemic agent, unspecified
0.049 0.951 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.049 0.951 0.000
Y43.6 Enzymes, not elsewhere classified
0.049 0.951 0.000
Y43.5 Acidifying and alkalising agents
0.049 0.951 0.000
Y43.2 Antineoplastic natural products
0.049 0.951 0.000
Y58.0 BCG vaccine
0.049 0.951 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.049 0.951 0.000
Y53.7 Emetics
0.049 0.951 0.000
Y53.6 Antidiarrhoeal drugs
0.049 0.951 0.000
Y53.5 Digestants
0.049 0.951 0.000
Y53.3 Saline and osmotic laxatives
0.049 0.951 0.000
Y53.2 Stimulant laxatives
0.049 0.951 0.000
Y53.0 Histamine H2-receptor antagonists
0.049 0.951 0.000
Y41.1 Antimycobacterial drugs
0.048 0.952 0.000
Y56.3 Emollients, demulcents and protectants
0.048 0.952 0.000
Y55.4 Expectorants
0.048 0.952 0.000
Y48.4 Anaesthetic, unspecified
0.048 0.952 0.000
Y45.0 Opioids and related analgesics
0.048 0.952 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.047 0.953 0.000
Y41.4 Anthelminthics
0.047 0.953 0.000
Y41.3 Other antiprotozoal drugs
0.047 0.953 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.047 0.953 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.047 0.953 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.047 0.953 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.047 0.953 0.000
Y59.3 Immunoglobulin
0.046 0.953 0.000
Y58.9 Other and unspecified bacterial vaccines
0.045 0.954 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.045 0.954 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.045 0.954 0.000
Y58.5 Diphtheria vaccine
0.045 0.954 0.000
Y58.4 Tetanus vaccine
0.045 0.954 0.000
Y58.3 Plague vaccine
0.045 0.954 0.000
Y58.2 Cholera vaccine
0.045 0.954 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.045 0.954 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.045 0.955 0.000
Y44.7 Plasma substitutes
0.045 0.955 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.045 0.955 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.045 0.955 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.045 0.955 0.000
Y56.9 Topical agent, unspecified
0.045 0.955 0.000
Y56.8 Other topical agents
0.045 0.955 0.000
Y56.7 Dental drugs, topically applied
0.045 0.955 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.045 0.955 0.000
Y56.5 Ophthalmological drugs and preparations
0.045 0.955 0.000
Y56.2 Local astringents and local detergents
0.045 0.955 0.000
Y56.1 Antipruritics
0.045 0.955 0.000
Y59.9 Vaccine or biological substance, unspecified
0.044 0.955 0.000
Y59.8 Other specified vaccines and biological substances
0.044 0.955 0.000
Y59.2 Protozoal vaccines
0.044 0.955 0.000
Y59.1 Rickettsial vaccines
0.044 0.955 0.000
Y59.0 Viral vaccines
0.044 0.955 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.044 0.955 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.044 0.955 0.000
Y55.5 Anticommon cold drugs
0.044 0.955 0.000
Y55.3 Antitussives
0.044 0.955 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.044 0.955 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.044 0.955 0.000
Y55.0 Oxytocic drugs
0.044 0.955 0.000
Y50.9 Central nervous system stimulant, unspecified
0.043 0.957 0.000
Y50.8 Other central nervous system stimulants
0.043 0.957 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.043 0.957 0.000
Y50.1 Opioid receptor antagonists
0.043 0.957 0.000
Y50.0 Analeptics
0.043 0.957 0.000
Y40.6 Rifamycins
0.043 0.957 0.000
Y40.3 Macrolides
0.043 0.957 0.000
Y46.6 Other and unspecified antiepileptics
0.043 0.957 0.000
Y48.5 Therapeutic gases
0.042 0.958 0.000
Y48.1 Parenteral anaesthetics
0.042 0.958 0.000
Y48.0 Inhaled anaesthetics
0.042 0.958 0.000
Y46.7 Anti-Parkinsonism drugs
0.042 0.958 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.042 0.958 0.000
Y54.3 Benzothiadiazine derivatives
0.042 0.958 0.000
Y40.5 Aminoglycosides
0.042 0.958 0.000
Y48.2 Other and unspecified general anaesthetics
0.041 0.958 0.000
Y46.8 Antispasticity drugs
0.041 0.958 0.000
Y46.5 Valproic acid
0.041 0.958 0.000
Y46.3 Deoxybarbiturates
0.041 0.958 0.000
Y46.1 Oxazolidinediones
0.041 0.958 0.000
Y46.0 Succinimides
0.041 0.958 0.000
Y44.5 Thrombolytic drugs
0.041 0.959 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.040 0.959 0.000
Y46.4 Iminostilbenes
0.040 0.960 0.000
Y40.0 Penicillins
0.040 0.960 0.000
Y54.7 Agents affecting calcification
0.039 0.961 0.000
Y44.2 Anticoagulants
0.039 0.961 0.000
Y40.8 Other systemic antibiotics
0.039 0.961 0.000
Y40.4 Tetracyclines
0.039 0.961 0.000
Y40.2 Chloramphenicol group
0.039 0.961 0.000
Y46.2 Hydantoin derivatives
0.038 0.961 0.000
Y40.7 Antifungal antibiotics, systemically used
0.038 0.962 0.000
Y54.9 Mineral salts, not elsewhere classified
0.038 0.962 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.038 0.962 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.038 0.962 0.000
Y54.0 Mineralocorticoids
0.038 0.962 0.000
Y54.5 Other diuretics
0.037 0.962 0.000
Y54.4 Loop [high-ceiling] diuretics
0.037 0.963 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.035 0.965 0.000
Y54.8 Agents affecting uric acid metabolism
0.034 0.966 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.034 0.966 0.000
Y57 Other and unspecified drugs and medicaments
0.032 0.968 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.031 0.968 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.030 0.970 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.030 0.970 0.000
Y48.3 Local anaesthetics
0.029 0.971 0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified
0.028 0.972 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.028 0.972 0.000
Y42.1 Thyroid hormones and substitutes
0.028 0.972 0.000
R39.1 Other difficulties with micturition
0.026 0.974 0.000
Y42.9 Other and unspecified hormone antagonists
0.025 0.974 0.000
Y42.4 Oral contraceptives
0.025 0.974 0.000
Y42.2 Antithyroid drugs
0.025 0.974 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.025 0.974 0.000
Y57.7 Vitamins, not elsewhere classified
0.023 0.977 0.000
Y57.4 Pharmaceutical excipients
0.023 0.977 0.000
Y57.3 Alcohol deterrents
0.023 0.977 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.023 0.977 0.000
Y57.1 Lipotropic drugs
0.023 0.977 0.000
Y57.0 Appetite depressants [anorectics]
0.023 0.977 0.000
Y57.6 Other diagnostic agents
0.021 0.979 0.000
Y57.9 Drug or medicament, unspecified
0.020 0.980 0.000
N80.0 Endometriosis of uterus
0.020 0.980 0.000
C91.1 Chronic lymphocytic leukaemia
0.000 0.981 0.019
Y57.5 X-ray contrast media
0.019 0.981 0.000
Y40.9 Systemic antibiotic, unspecified
0.018 0.982 0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified
0.018 0.982 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.017 0.982 0.000
N31.8 Other neuromuscular dysfunction of bladder
0.017 0.983 0.000
N03.9 Unspecified
0.017 0.983 0.000
Y57.8 Other drugs and medicaments
0.015 0.984 0.000
Y42.7 Androgens and anabolic congeners
0.015 0.985 0.000
R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract
0.014 0.986 0.000
N03 Chronic nephritic syndrome
0.014 0.986 0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified
0.013 0.987 0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified
0.013 0.987 0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
0.013 0.987 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.012 0.988 0.000
N00-N08 Glomerular diseases
0.012 0.988 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.011 0.989 0.000
N02 Recurrent and persistent haematuria
0.011 0.989 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.010 0.990 0.000
N03.8 Other
0.010 0.990 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.010 0.990 0.000
N03.6 Dense deposit disease
0.010 0.990 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.010 0.990 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.010 0.990 0.000
N03.2 Diffuse membranous glomerulonephritis
0.010 0.990 0.000
N03.1 Focal and segmental glomerular lesions
0.010 0.990 0.000
N03.0 Minor glomerular abnormality
0.010 0.990 0.000
N05 Unspecified nephritic syndrome
0.009 0.991 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.009 0.991 0.000
Y43.3 Other antineoplastic drugs
0.009 0.991 0.000
E23.0 Hypopituitarism
0.009 0.991 0.000
N02.8 Other
0.009 0.991 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.009 0.991 0.000
N06 Isolated proteinuria with specified morphological lesion
0.009 0.991 0.000
N01 Rapidly progressive nephritic syndrome
0.009 0.991 0.000
N00 Acute nephritic syndrome
0.009 0.991 0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified
0.008 0.992 0.000
R93 Abnormal findings on diagnostic imaging of other body structures
0.008 0.992 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.008 0.992 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.008 0.992 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.008 0.992 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.008 0.992 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.008 0.992 0.000
N02.2 Diffuse membranous glomerulonephritis
0.008 0.992 0.000
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
0.008 0.992 0.000
N05.9 Unspecified
0.008 0.992 0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
0.008 0.992 0.000
Z89.6 Acquired absence of leg above knee
0.008 0.992 0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs
0.008 0.992 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.008 0.992 0.000
N02.6 Dense deposit disease
0.008 0.992 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.008 0.992 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.008 0.992 0.000
N02.1 Focal and segmental glomerular lesions
0.008 0.992 0.000
N02.0 Minor glomerular abnormality
0.008 0.992 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.007 0.993 0.000
N04 Nephrotic syndrome
0.007 0.993 0.000
N05.7 Diffuse crescentic glomerulonephritis
0.007 0.993 0.000
N02.9 Unspecified
0.007 0.993 0.000
N05.6 Dense deposit disease
0.007 0.993 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.007 0.993 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.007 0.993 0.000
N05.0 Minor glomerular abnormality
0.007 0.993 0.000
N05.8 Other
0.007 0.993 0.000
E23 Hypofunction and other disorders of pituitary gland
0.007 0.993 0.000
R93.6 Abnormal findings on diagnostic imaging of limbs
0.007 0.993 0.000
I63 Cerebral infarction
0.007 0.993 0.000
N00.9 Unspecified
0.006 0.993 0.000
N00.8 Other
0.006 0.993 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.006 0.993 0.000
N00.6 Dense deposit disease
0.006 0.993 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.993 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.993 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.993 0.000
N00.2 Diffuse membranous glomerulonephritis
0.006 0.993 0.000
N00.1 Focal and segmental glomerular lesions
0.006 0.993 0.000
N00.0 Minor glomerular abnormality
0.006 0.993 0.000
N01.9 Unspecified
0.006 0.993 0.000
N01.8 Other
0.006 0.993 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.006 0.993 0.000
N01.6 Dense deposit disease
0.006 0.993 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.993 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.993 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.993 0.000
N01.2 Diffuse membranous glomerulonephritis
0.006 0.993 0.000
N01.1 Focal and segmental glomerular lesions
0.006 0.993 0.000
N01.0 Minor glomerular abnormality
0.006 0.993 0.000
N06.9 Unspecified
0.006 0.993 0.000
N06.8 Other
0.006 0.993 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.006 0.993 0.000
N06.6 Dense deposit disease
0.006 0.993 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.993 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.993 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.993 0.000
N06.2 Diffuse membranous glomerulonephritis
0.006 0.993 0.000
N06.1 Focal and segmental glomerular lesions
0.006 0.993 0.000
N06.0 Minor glomerular abnormality
0.006 0.993 0.000
N07.9 Unspecified
0.006 0.993 0.000
N07.8 Other
0.006 0.993 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.006 0.993 0.000
N07.6 Dense deposit disease
0.006 0.993 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.006 0.993 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.006 0.993 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.006 0.993 0.000
N07.2 Diffuse membranous glomerulonephritis
0.006 0.993 0.000
N07.1 Focal and segmental glomerular lesions
0.006 0.993 0.000
N07.0 Minor glomerular abnormality
0.006 0.993 0.000
N05.2 Diffuse membranous glomerulonephritis
0.006 0.994 0.000
E23.7 Disorder of pituitary gland, unspecified
0.006 0.994 0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries
0.006 0.994 0.000
I73.0 Raynaud's syndrome
0.000 0.994 0.006
J38.3 Other diseases of vocal cords
0.006 0.994 0.000
N99.3 Prolapse of vaginal vault after hysterectomy
0.006 0.994 0.000
N85.0 Endometrial glandular hyperplasia
0.006 0.994 0.000
I63.9 Cerebral infarction, unspecified
0.006 0.994 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.005 0.994 0.000
N04.8 Other
0.005 0.994 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.005 0.994 0.000
N04.6 Dense deposit disease
0.005 0.994 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.005 0.994 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.005 0.994 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.005 0.994 0.000
N04.2 Diffuse membranous glomerulonephritis
0.005 0.994 0.000
N04.1 Focal and segmental glomerular lesions
0.005 0.994 0.000
N04.0 Minor glomerular abnormality
0.005 0.994 0.000
Y42.5 Other oestrogens and progestogens
0.005 0.994 0.001
N05.1 Focal and segmental glomerular lesions
0.005 0.995 0.000
R39 Other symptoms and signs involving the urinary system
0.005 0.995 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.005 0.995 0.000
E23.1 Drug-induced hypopituitarism
0.005 0.995 0.000
E23.2 Diabetes insipidus
0.005 0.995 0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries
0.005 0.995 0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation
0.005 0.995 0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
0.005 0.995 0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries
0.005 0.995 0.000
Z89.5 Acquired absence of leg at or below knee
0.005 0.995 0.000
M87.9 Osteonecrosis, unspecified
0.005 0.995 0.000
H33 Retinal detachments and breaks
0.000 0.995 0.005
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)
0.005 0.995 0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries
0.005 0.995 0.000
M87 Osteonecrosis
0.005 0.995 0.000
M87.91 Osteonecrosis, unspecified (Shoulder region)
0.005 0.995 0.000
C91 Lymphoid leukaemia
0.000 0.995 0.005
M87.2 Osteonecrosis due to previous trauma
0.004 0.995 0.000
Z89 Acquired absence of limb
0.005 0.995 0.000
R44.3 Hallucinations, unspecified
0.005 0.995 0.000
N04.9 Unspecified
0.004 0.996 0.000
E20-E35 Disorders of other endocrine glands
0.004 0.996 0.000
E27.1 Primary adrenocortical insufficiency
0.004 0.996 0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract
0.004 0.996 0.000
M87.97 Osteonecrosis, unspecified (Ankle and foot)
0.004 0.996 0.000
M90.7 Fracture of bone in neoplastic disease
0.004 0.996 0.000
R39.0 Extravasation of urine
0.004 0.996 0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)
0.004 0.996 0.000
E23.6 Other disorders of pituitary gland
0.004 0.996 0.000
E22 Hyperfunction of pituitary gland
0.004 0.996 0.000
M87.98 Osteonecrosis, unspecified (Other)
0.004 0.996 0.000
R44 Other symptoms and signs involving general sensations and perceptions
0.004 0.996 0.000
R44.0 Auditory hallucinations
0.004 0.996 0.000
R39.2 Extrarenal uraemia
0.004 0.996 0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)
0.004 0.996 0.000
E27 Other disorders of adrenal gland
0.004 0.996 0.000
Y83.2 Surgical operation with anastomosis, bypass or graft
0.004 0.996 0.000
M90 Osteopathies in diseases classified elsewhere
0.004 0.996 0.000
M87.8 Other osteonecrosis
0.004 0.996 0.000
M87.25 Osteonecrosis due to previous trauma (Pelvic region and thigh)
0.004 0.996 0.000
M86-M90 Other osteopathies
0.004 0.996 0.000
M90.71 Fracture of bone in neoplastic disease (Shoulder region)
0.004 0.996 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.004 0.996 0.000
E24 Cushing's syndrome
0.004 0.996 0.000
R44.1 Visual hallucinations
0.004 0.996 0.000
M87.99 Osteonecrosis, unspecified (Site unspecified)
0.004 0.996 0.000
M87.94 Osteonecrosis, unspecified (Hand)
0.004 0.996 0.000
M87.93 Osteonecrosis, unspecified (Forearm)
0.004 0.996 0.000
M87.92 Osteonecrosis, unspecified (Upper arm)
0.004 0.996 0.000
M87.90 Osteonecrosis, unspecified (Multiple sites)
0.004 0.996 0.000
E22.0 Acromegaly and pituitary gigantism
0.004 0.996 0.000
R44.2 Other hallucinations
0.004 0.996 0.000
E26 Hyperaldosteronism
0.004 0.996 0.000
Z89.8 Acquired absence of upper and lower limbs [any level]
0.004 0.996 0.000
M87.3 Other secondary osteonecrosis
0.004 0.996 0.000
M87.1 Osteonecrosis due to drugs
0.004 0.996 0.000
M87.0 Idiopathic aseptic necrosis of bone
0.004 0.996 0.000
M89.8 Other specified disorders of bone
0.004 0.996 0.000
Z89.2 Acquired absence of upper limb above wrist
0.004 0.996 0.000
H35.0 Background retinopathy and retinal vascular changes
0.004 0.996 0.000
I63.8 Other cerebral infarction
0.004 0.996 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.996 0.003
C91.7 Other lymphoid leukaemia
0.000 0.996 0.003
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.996 0.003
C91.5 Adult T-cell leukaemia
0.000 0.996 0.003
C91.3 Prolymphocytic leukaemia
0.000 0.996 0.003
C91.2 Subacute lymphocytic leukaemia
0.000 0.996 0.003
M87.29 Osteonecrosis due to previous trauma (Site unspecified)
0.003 0.996 0.000
M87.28 Osteonecrosis due to previous trauma (Other)
0.003 0.996 0.000
M87.26 Osteonecrosis due to previous trauma (Lower leg)
0.003 0.996 0.000
M87.24 Osteonecrosis due to previous trauma (Hand)
0.003 0.996 0.000
M87.23 Osteonecrosis due to previous trauma (Forearm)
0.003 0.996 0.000
M87.22 Osteonecrosis due to previous trauma (Upper arm)
0.003 0.996 0.000
M87.21 Osteonecrosis due to previous trauma (Shoulder region)
0.003 0.996 0.000
M89.86 Other specified disorders of bone (Lower leg)
0.003 0.996 0.000
C91.0 Acute lymphoblastic leukaemia
0.000 0.996 0.003
Z89.3 Acquired absence of both upper limbs [any level]
0.003 0.996 0.000
Z89.1 Acquired absence of hand and wrist
0.003 0.996 0.000
E25 Adrenogenital disorders
0.003 0.996 0.000
H33.1 Retinoschisis and retinal cysts
0.000 0.996 0.003
M87.27 Osteonecrosis due to previous trauma (Ankle and foot)
0.003 0.997 0.000
E31 Polyglandular dysfunction
0.003 0.997 0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures
0.003 0.997 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.003 0.997 0.000
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
0.003 0.997 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.003 0.997 0.000
E32 Diseases of thymus
0.003 0.997 0.000
E30 Disorders of puberty, not elsewhere classified
0.003 0.997 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.003 0.997 0.000
E10.3 With ophthalmic complications
0.003 0.997 0.000
M87.96 Osteonecrosis, unspecified (Lower leg)
0.003 0.997 0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]
0.003 0.997 0.000
M89.81 Other specified disorders of bone (Shoulder region)
0.003 0.997 0.000
M90.79 Fracture of bone in neoplastic disease (Site unspecified)
0.003 0.997 0.000
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)
0.003 0.997 0.000
M90.76 Fracture of bone in neoplastic disease (Lower leg)
0.003 0.997 0.000
M90.74 Fracture of bone in neoplastic disease (Hand)
0.003 0.997 0.000
M90.73 Fracture of bone in neoplastic disease (Forearm)
0.003 0.997 0.000
M90.70 Fracture of bone in neoplastic disease (Multiple sites)
0.003 0.997 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.003 0.997 0.000
M89 Other disorders of bone
0.003 0.997 0.000
M87.85 Other osteonecrosis (Pelvic region and thigh)
0.003 0.997 0.000
M88 Paget's disease of bone [osteitis deformans]
0.003 0.997 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.003 0.997 0.000
E22.8 Other hyperfunction of pituitary gland
0.003 0.997 0.000
E24.2 Drug-induced Cushing's syndrome
0.003 0.997 0.000
E28 Ovarian dysfunction
0.003 0.997 0.000
E24.9 Cushing's syndrome, unspecified
0.003 0.997 0.000
E26.0 Primary hyperaldosteronism
0.003 0.997 0.000
M89.83 Other specified disorders of bone (Forearm)
0.003 0.997 0.000
J32.9 Chronic sinusitis, unspecified
0.003 0.997 0.000
Z89.9 Acquired absence of limb, unspecified
0.003 0.997 0.000
Z89.4 Acquired absence of foot and ankle
0.003 0.997 0.000
E24.0 Pituitary-dependent Cushing's disease
0.003 0.997 0.000
E27.5 Adrenomedullary hyperfunction
0.003 0.997 0.000
E27.0 Other adrenocortical overactivity
0.003 0.997 0.000
M90.78 Fracture of bone in neoplastic disease (Other)
0.003 0.997 0.000
E26.9 Hyperaldosteronism, unspecified
0.003 0.997 0.000
J95.8 Other postprocedural respiratory disorders
0.000 0.997 0.003
M90.8 Osteopathy in other diseases classified elsewhere
0.003 0.997 0.000
M90.6 Osteitis deformans in neoplastic disease
0.003 0.997 0.000
M90.5 Osteonecrosis in other diseases classified elsewhere
0.003 0.997 0.000
M90.4 Osteonecrosis due to heamoglobinopathy
0.003 0.997 0.000
M90.3 Osteonecrosis in caisson disease
0.003 0.997 0.000
M90.2 Osteopathy in other infectious diseases classified elsewhere
0.003 0.997 0.000
M90.0 Tuberculosis of bone
0.003 0.997 0.000
M87.89 Other osteonecrosis (Site unspecified)
0.003 0.997 0.000
M87.88 Other osteonecrosis (Other)
0.003 0.997 0.000
M87.87 Other osteonecrosis (Ankle and foot)
0.003 0.997 0.000
M87.86 Other osteonecrosis (Lower leg)
0.003 0.997 0.000
M87.84 Other osteonecrosis (Hand)
0.003 0.997 0.000
M87.83 Other osteonecrosis (Forearm)
0.003 0.997 0.000
M87.82 Other osteonecrosis (Upper arm)
0.003 0.997 0.000
M87.81 Other osteonecrosis (Shoulder region)
0.003 0.997 0.000
M87.80 Other osteonecrosis (Multiple sites)
0.003 0.997 0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions
0.003 0.997 0.000
H35.8 Other specified retinal disorders
0.003 0.997 0.000
N83.0 Follicular cyst of ovary
0.003 0.997 0.000
E24.8 Other Cushing's syndrome
0.003 0.997 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.003 0.997 0.000
E24.3 Ectopic ACTH syndrome
0.003 0.997 0.000
E24.1 Nelson's syndrome
0.003 0.997 0.000
M86 Osteomyelitis
0.003 0.997 0.000
M89.5 Osteolysis
0.003 0.997 0.000
J32.2 Chronic ethmoidal sinusitis
0.003 0.997 0.000
L53.9 Erythematous condition, unspecified
0.000 0.997 0.003
E21.3 Hyperparathyroidism, unspecified
0.003 0.997 0.000
E26.8 Other hyperaldosteronism
0.003 0.997 0.000
E26.1 Secondary hyperaldosteronism
0.003 0.997 0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)
0.003 0.997 0.000
M87.09 Idiopathic aseptic necrosis of bone (Site unspecified)
0.003 0.997 0.000
M87.08 Idiopathic aseptic necrosis of bone (Other)
0.003 0.997 0.000
M87.07 Idiopathic aseptic necrosis of bone (Ankle and foot)
0.003 0.997 0.000
M87.06 Idiopathic aseptic necrosis of bone (Lower leg)
0.003 0.997 0.000
M87.05 Idiopathic aseptic necrosis of bone (Pelvic region and thigh)
0.003 0.997 0.000
M87.04 Idiopathic aseptic necrosis of bone (Hand)
0.003 0.997 0.000
M87.03 Idiopathic aseptic necrosis of bone (Forearm)
0.003 0.997 0.000
M87.02 Idiopathic aseptic necrosis of bone (Upper arm)
0.003 0.997 0.000
M87.01 Idiopathic aseptic necrosis of bone (Shoulder region)
0.003 0.997 0.000
M87.00 Idiopathic aseptic necrosis of bone (Multiple sites)
0.003 0.997 0.000
M87.19 Osteonecrosis due to drugs (Site unspecified)
0.003 0.997 0.000
M87.18 Osteonecrosis due to drugs (Other)
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.